Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1527)
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,292
Price
$276.26
Total Value
$356.93K
Shares Held After
0
% of Holdings
100.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,450
Price
$18.00
Total Value
$26.10K
Shares Held After
51,776
% of Holdings
2.7%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$117.94
Total Value
$1.06M
Shares Held After
7,825
% of Holdings
53.5%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
9,810
Price
$12.00
Total Value
$117.72K
Shares Held After
8,617
% of Holdings
53.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,175
Price
$20.00
Total Value
$43.50K
Shares Held After
62,371
% of Holdings
3.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
3,000
Price
$20.00
Total Value
$60.00K
Shares Held After
67,845
% of Holdings
4.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
11,845
Price
$20.22
Total Value
$239.52K
Shares Held After
59,992
% of Holdings
16.5%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
7,557
Price
$3.14
Total Value
$23.73K
Shares Held After
0
% of Holdings
100.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,500
Price
$10.00
Total Value
$25.00K
Shares Held After
130,180
% of Holdings
1.9%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,000
Price
$9.47
Total Value
$142.05K
Shares Held After
132,680
% of Holdings
10.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,117
Price
$0.90
Total Value
$3.70K
Shares Held After
1,724,349
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
15,112
Price
$0.90
Total Value
$13.59K
Shares Held After
1,140,434
% of Holdings
1.3%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,311
Price
$0.90
Total Value
$10.17K
Shares Held After
3,669,802
% of Holdings
0.3%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
7,794
Price
$0.90
Total Value
$7.01K
Shares Held After
1,182,429
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
75,000
Price
$0.04
Total Value
$3.38K
Shares Held After
93,769,319
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
17,426
Price
$14.25
Total Value
$248.32K
Shares Held After
176,649
% of Holdings
9.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
101,579
Price
$14.25
Total Value
$1.45M
Shares Held After
834,673
% of Holdings
10.8%
Nuvation Bio Inc. (NUVB)
Markel Stacy — CHIEF PEOPLE OFFICER
Shares
125,000
Price
$6.03
Total Value
$753.19K
Shares Held After
32,591
% of Holdings
79.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
425
Price
$25.91
Total Value
$11.01K
Shares Held After
17,413
% of Holdings
2.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,969
Price
$24.84
Total Value
$48.91K
Shares Held After
16,988
% of Holdings
11.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
6,836
Price
$24.12
Total Value
$164.88K
Shares Held After
15,019
% of Holdings
45.5%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
63,000
Price
$6.02
Total Value
$379.19K
Shares Held After
53,000
% of Holdings
54.3%
Nuvation Bio Inc. (NUVB)
Sauvage Philippe — Chief Financial Officer
Shares
47,668
Price
$6.01
Total Value
$286.37K
Shares Held After
12,673
% of Holdings
79.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
39,000
Price
$1.00
Total Value
$39.00K
Shares Held After
166,338
% of Holdings
23.4%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
2,196
Price
$68.57
Total Value
$150.58K
Shares Held After
8,383
% of Holdings
20.8%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
1,697
Price
$28.06
Total Value
$47.62K
Shares Held After
897,240
% of Holdings
0.2%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
14,067
Price
$27.69
Total Value
$389.48K
Shares Held After
898,937
% of Holdings
1.5%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
2,196
Price
$68.57
Total Value
$150.58K
Shares Held After
9,259
% of Holdings
19.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,277
Price
$3.20
Total Value
$7.29K
Shares Held After
117,145
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
88
Price
$38.43
Total Value
$3.38K
Shares Held After
198,244
% of Holdings
0.0%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
18,412
Price
$37.93
Total Value
$698.39K
Shares Held After
198,332
% of Holdings
8.5%
Immuneering Corp (IMRX)
Zeskind Benjamin J. — Director
Shares
2,400
Price
$4.56
Total Value
$10.95K
Shares Held After
2,315,252
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
1,657
Price
$21.47
Total Value
$35.58K
Shares Held After
3,848,256
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
71,629
Price
$21.04
Total Value
$1.51M
Shares Held After
3,849,913
% of Holdings
1.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
23,865
Price
$26.05
Total Value
$621.67K
Shares Held After
319,079
% of Holdings
7.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,227
Price
$546.00
Total Value
$669.94K
Shares Held After
40,513
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,407
Price
$545.19
Total Value
$1.86M
Shares Held After
41,740
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,329
Price
$544.29
Total Value
$723.36K
Shares Held After
45,147
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
900
Price
$543.10
Total Value
$488.79K
Shares Held After
46,476
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,444
Price
$542.13
Total Value
$782.83K
Shares Held After
47,376
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
894
Price
$540.99
Total Value
$483.64K
Shares Held After
48,820
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
299
Price
$540.24
Total Value
$161.53K
Shares Held After
49,714
% of Holdings
0.6%
Spyre Therapeutics, Inc. (SYRE)
Fairmount Funds Management LLC — Director
Shares
4,684,781
Price
$85.31
Total Value
$399.66M
Shares Held After
0
% of Holdings
100.0%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$79.51
Total Value
$278.29K
Shares Held After
153,902
% of Holdings
2.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,116
Price
$0.96
Total Value
$3.94K
Shares Held After
1,728,466
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
15,111
Price
$0.96
Total Value
$14.47K
Shares Held After
1,155,546
% of Holdings
1.3%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
9,700
Price
$72.66
Total Value
$704.80K
Shares Held After
54,324
% of Holdings
15.2%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,310
Price
$0.96
Total Value
$10.83K
Shares Held After
3,681,113
% of Holdings
0.3%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
7,794
Price
$0.96
Total Value
$7.46K
Shares Held After
1,190,223
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
65,000
Price
$0.04
Total Value
$2.92K
Shares Held After
93,694,319
% of Holdings
0.1%
Showing 1–50 of 1527 transactions (page 1 of 31)